[Ulcerative colitis and Crohn's disease]

Nihon Rinsho. 2005 May:63 Suppl 5:507-11.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Antineutrophil Cytoplasmic / blood
  • Antibodies, Fungal / blood
  • Antibodies, Monoclonal / therapeutic use
  • Appendectomy
  • Biomarkers / blood
  • Colitis, Ulcerative* / diagnosis
  • Colitis, Ulcerative* / etiology
  • Colitis, Ulcerative* / physiopathology
  • Colitis, Ulcerative* / therapy
  • Crohn Disease* / diagnosis
  • Crohn Disease* / etiology
  • Crohn Disease* / physiopathology
  • Crohn Disease* / therapy
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Intestines / microbiology
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / physiology
  • Mesalamine / therapeutic use
  • Mutation
  • Nod2 Signaling Adaptor Protein
  • Probiotics / therapeutic use
  • Saccharomyces cerevisiae / immunology
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Anti-Bacterial Agents
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Fungal
  • Antibodies, Monoclonal
  • Biomarkers
  • Immunosuppressive Agents
  • Intracellular Signaling Peptides and Proteins
  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
  • Tumor Necrosis Factor-alpha
  • Mesalamine
  • Infliximab